When Hyman, Phelps & McNamara, P.C. launched the FDA Law Blog 2 years ago today – Is that 14 in “blog years”? It certainly seems like it, if not more! – we could hardly imagine how successful it would become and how our subscribers (and the Food and Drug Bar generally) would come to rely on it for timely information and insightful commentary on myriad FDA-related issues. In 2007, blogs were just beginning to be recognized as a vibrant and dynamic medium for conveying thoughts and ideas on a given topic. Today, there are millions of blogs in the blogosphere covering just about any topic imaginable.
During our lifetime, we have made over 450 posts, have garnered thousands of subscribers from around the world, and have been recognized as one of the top blogs covering the life sciences – and certainly the best (we believe) blog covering FDA. In the past year, we have added useful new functions to the blog, including the FDC Act § 505(q) Citizen Petition Tracker and the FDA Legislation Tracker. And yesterday, we introduced the Risk Evaluation and Mitigation Strategy (REMS) Tracker.
We thank our subscribers for their continued interest in the blog, and our Hyman, Phelps & McNamara, P.C. colleagues for their time and dedication to writing interesting and informative posts. Onward to another year of “covering topics of interest to FDA-regulated companies, fellow food and drug and healthcare lawyers and regulatory personnel, as well as people just generally interested in FDA law,” as we first promised.